Goldman Sachs assumed coverage of Universal Health (UHS) with a Neutral rating and $219 price target The firm sees favorable trends continuing for the hospital sector through 2028, including supportive labor dynamics, tailwinds from previously approved pro-utilization government policies, and the industry showing more effective adaptation to structural changes. However, the sector will face new pressures from implementation of the One Big Beautiful Bill, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health price target raised to $249 from $210 at Wells Fargo
- Universal Health Faces $500 Million Verdict in Nevada
- Universal Health price target lowered to $250 from $259 at Barclays
- Ex-Dividend Date Nearing for These 10 Stocks – Week of September 1, 2025
- Universal Health price target raised to $206 from $201 at RBC Capital